Skip to main content
OPTIBIOTIX HEALTH PLC logo

OPTIBIOTIX HEALTH PLC — Investor Relations & Filings

Ticker · OPTI ISIN · GB00BP0RTP38 LEI · 213800UKYQFT941QHS14 IL Manufacturing
Open in API
Filings indexed 474 across all filing types
Latest filing 2026-05-14 Regulatory Filings
Country GB United Kingdom
Listing IL OPTI

About OPTIBIOTIX HEALTH PLC

https://www.optibiotix.com/

OptiBiotix Health PLC is a life sciences company specializing in the research and development of technologies that modulate the human microbiome. The company identifies and develops microbial strains, compounds, and formulations for use as food ingredients, dietary supplements, and active compounds. Its primary focus is on the prevention and management of chronic lifestyle diseases, including obesity, cardiovascular health issues such as high cholesterol, and diabetes. OptiBiotix's approach is founded on strong scientific evidence, with its product pipeline supported by clinical human studies. The company provides these clinically proven ingredients and white-label solutions to partners in the food, health, and wellness sectors.

Recent filings

Filing Released Lang Actions
SweetBiotix® Sampling
Regulatory Filings Classification · 80% confidence The document is a non-regulatory “Reach” announcement via RNS describing a product sampling event (SweetBiotix® Sampling) and invitation to shareholders. It contains no financial results, voting information, filings of reports, or corporate actions. It is essentially a general press release distributed through RNS Reach, fitting the fallback category for miscellaneous regulatory announcements.
2026-05-14 English
Partial Disposal of Shares in SkinBioTherapeutics
Regulatory Filings
2026-05-01 English
Trading Update
Earnings Release Classification · 90% confidence The document is a trading update published via RNS providing unaudited key financial highlights for the year ended 31 December 2025. It is not a full statutory report (Annual Report or Interim Report) but an initial announcement of periodical financial results. This fits the definition of an Earnings Release (ER). FY 2025
2026-04-01 English
WellBiome® clinical trial on surgical outcomes
Regulatory Filings Classification · 98% confidence The document is an official announcement distributed via the London Stock Exchange's RNS (Regulatory News Service). It details a specific corporate development regarding a clinical trial for the company's product, WellBiome. Since it does not fit into specific categories like financial results (ER/IR), board changes (MANG), or share transactions (POS/DIRS), and serves as a general regulatory disclosure of material information, it is classified as a Regulatory Filing (RNS).
2026-02-24 English
Statement: SkinBioTherapeutics Announcement
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from OptiBiotix Health plc. It functions as a corporate statement addressing market uncertainty regarding the company's holdings in SkinBioTherapeutics and providing an update on its own cash position and business progress. It does not constitute a full financial report, audit, or proxy statement, but rather a general regulatory disclosure of material information to the market. Therefore, it falls under the 'Regulatory Filings' category.
2026-02-17 English
Large Order and Record Early Orders for 2026
Regulatory Filings Classification · 95% confidence The document is an RNS (Regulatory News Service) announcement from OptiBiotix Health PLC regarding a large commercial order and sales performance. It is a standard corporate news release detailing business operations, order volumes, and market outlook. It does not constitute a full financial report, audit, or proxy statement. As it is a general regulatory announcement regarding company business updates, it falls under the RNS category.
2026-01-21 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.